Filter your results
- 2
- 2
- 2
- 1
- 1
- 2
- 1
- 1
- 1
- 2
- 2
- 1
- 1
- 1
|
|
sorted by
|
|
A novel VEGF-independent antiangiogenic therapy targeting the CD160 receptorMédecine/Sciences, 2012, 28 (1), pp.37-38. ⟨10.1051/medsci/2012281013⟩
Journal articles
inserm-02168009v1
|
||
|
Identification and characterization of a transmembrane isoform of CD160 (CD160-TM), a unique activating receptor selectively expressed upon human NK cell activation.Journal of Immunology, 2009, 182 (1), pp.63-71
Journal articles
inserm-00352331v1
|